XKRX
195870
Market cap835mUSD
Oct 08, Last price
66,000.00KRW
1D
2.01%
1Q
11.11%
Jan 2017
409.65%
IPO
329.97%
Name
Haesung DS Co Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
HAESUNG DS Co., Ltd., a South Korean-based enterprise, specializes in the global manufacturing and sale of semiconductor components. Its product offerings include lead frames, which are vital for applications in the automotive industry, mobile technology, personal computing, and various consumer electronics. The company also supplies package substrates critical for flash memory, mobile DRAM, and graphic DRAM, alongside graphene, which finds utility across sectors such as energy, sensors, biotechnology, military applications, inks, and display technologies. Furthermore, HAESUNG DS is actively developing bio-healthcare sensors, engineered to track physical activity and health conditions, with a focus on their integration into wearable devices and other IT products. Founded in 1984, the company's headquarters are situated in Seoul, South Korea.
Key people
Seok Hyeon Hong
Vice President · since 2023
Jong Wu Park
Vice President · since 2024
Jeong Su Byun
Managing Director
Seong Su Cho
Managing Director · since 2023
Jae Gu Jung
Managing Director
Hyeon Su Yoon
Managing Director · since 2023
Wu Gwang Cheon
Assistant Managing Director
Ju Hyeong Ha
Assistant Managing Director
Seok Gyun Jang
Assistant Managing Director
Jun Hyeon Kim
Assistant Managing Director
Yeong Sik Choi
Co-President, Chief Executive Officer, Director · since 2025
Co-President, Director
Vice Chairman
Chairman
Other Non-Executive Director · since 2024
Yo Hwan Goh
Non-Executive Independent Director · since 2023
Yun Hui Ha
Non-Executive Independent Director
Won Jung Jeon
Non-Executive Independent Director · since 2022
Valuation
Title KRW in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||